Skip to main content
PMC home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 2001 Feb;92(2):211–219. doi: 10.1111/j.1349-7006.2001.tb01084.x

Involvement of the Multidrug Resistance Protein 3 in Drug Sensitivity and Its Expression in Human Glioma

Sei Haga 1, Eiji Hinoshita 1, Kiyonobu Ikezaki 2, Masashi Fukui 2, George L Scheffer 3, Takeshi Uchiumi 1,✉, Michihiko Kuwano 1
PMCID: PMC5926688  PMID: 11223551

Abstract

The multidrug resistance protein (MRP) family belongs to the ATP‐binding cassette superfamily (ABC) of transporters, which are involved in ATP‐dependent transport of hydrophobic compounds. One of the MRP family, MRP1, is partially associated with the multidrug resistance phe‐notype in brain tumors. In this study, we asked whether another MRP family gene, MRP3, could affect drug sensitivity to anticancer agents in human glioma cell lines and clinical glioma specimens. We first produced two antisense transfectants by introduction of antisense MRP3 cDNA into the glioma cell line NHG2, which endogenously expresses MRP3. The two MRP3 antisense transfectants showed 2‐ to 5‐fold increases in drug sensitivity to etoposide and cisplatin compared with NHG2 cells, but their sensitivity to vincristine or nitrosourea was not changed. Two MRP3 cDNA sense transfectants of pig kidney cell lines showed 4‐ to 6‐fold drug resistance to etoposide, but only 1.4‐ to 1.5‐fold to cisplatin. We next compared the mRNA levels of four ABC transporters, multi‐drug resistance 1 (MDR1), MRP1, MRP2 and MRP3 in clinical samples, including 34 patients with gliomas, by quantitative RT‐PCR analysis. In some of the clinical samples, increased expression of MRP1 and MRP3 was apparent in malignant gliomas. In situ hybridization revealed that glioma cells were stained with MRP3 probe. MRP3 may modulate drug sensitivity to certain anticancer agents in human gliomas.

Keywords: Glioblastoma, MRP subfamily, ABC transporter, Anticancer agents

Full Text

The Full Text of this article is available as a PDF (1.1 MB).

References

  • 1.Cole , S. P. , Bhardwaj , G. , Gerlach , J. H. , Mackie , J. E. , Grant , C. E. , Almquist , K. C. , Stewart , A. J. , Kurz , E. U. , Duncan , A. M. . and Deeley , R. G.Overexpression of a transporter gene in a multidrug‐resistant human lung cancer cell line . Science , 258 , 1650 – 1654 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 2.Gottesman , M. . and Pastan , I.Biochemistry of multidrug resistance mediated by the multidrug transporter . Annu. Rev. Biochem. , 62 , 385 – 427 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 3.Endicott , J. A. . and Ling , V.The biochemistry of P‐glycoprotein‐mediated multidrug resistance . Annu. Rev. Biochem. , 58 , 137 – 141 ( 1989. ). [DOI] [PubMed] [Google Scholar]
  • 4.Loe , D. W. , Deeley , R. G. . and Cole , S. P.Biology of the multidrug resistance‐associated protein, MRP . Eur. J. Cancer , 32A , 945 – 957 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 5.Kool , M. , de Haas , M. , Scheffer , G. L. , Scheper , R. J. , van Eijk , M. J. , Juijn , J. A. , Baas , F. . and Borst , P.Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance‐associated protein gene (MRP1), in human cancer cell lines . Cancer Res. , 57 , 3537 – 3547 ( 1997. ). [PubMed] [Google Scholar]
  • 6.Paulusma , C. C. . and Oude Elferink , R. P.The canalicular multispecific organic anion transporter and conjugated hyperbilirubinemia in rat and man . J. Mol. Med. , 75 , 420 – 428 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 7.Taniguchi , K. , Wada , M. , Kohno , K. , Nakamura , T. , Kawabe , T. , Kawakami , M. , Kagotani , K. , Okumura , K. , Akiyama , S. . and Kuwano , M.A human canalicular multi‐specific organic anion transporter (cMOAT) gene is overexpressed in cisplatin‐resistant human cancer cell lines with decreased drug accumulation . Cancer Res. , 56 , 4124 – 4129 ( 1996. ). [PubMed] [Google Scholar]
  • 8.Wada , M. , Toh , S. , Taniguchi , K. , Nakamura , T. , Uchiumi , T. , Kohno , K. , Yoshida , I. , Kimura , A. , Sakisaka , S. , Adachi , Y. . and Kuwano , M.Mutations in the canalicular multispecific organic anion transporter (cMOAT) gene, a novel ABC transporter, in patients with hyperbilirubinemia II/Dubin‐Johnson syndrome . Hum. Mol. Genet. , 7 , 203 – 207 ( 1998. ). [DOI] [PubMed] [Google Scholar]
  • 9.Toh , S. , Wada , M. , Uchiumi , T. , Inokuchi , A. , Makino , Y. , Horie , Y. , Adachi , Y. , Sakisaka , S. . and Kuwano , M.Genomic structure of the canalicular multispecific organic anion‐transporter gene (MRP2/cMOAT) and mutations in the ATP‐binding‐cassette region in Dubin‐Johnson syndrome . Am. J. Hum. Genet. , 64 , 739 – 746 ( 1999. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Kiuchi , Y. , Suzuki , H. , Hirohashi , T. , Tyson , C. A. . and Sugiyama , Y.cDNA cloning and inducible expression of human multidrug resistance associated protein 3 (MRP3) . FEBS Lett. , 433 , 149 – 152 ( 1998. ). [DOI] [PubMed] [Google Scholar]
  • 11.Uchiumi , T. , Hinoshita , E. , Haga , S. , Nakamura , T. , Tanaka , T. , Toh , S. , Furukawa , M. , Kawabe , T. , Wada , M. , Kagotani , K. , Okumura , K. , Kohno , K. , Akiyama , S. . and Kuwano , M.Isolation of a novel human canalicular multispecific organic anion transporter, cMOAT2/MRP3, and its expression in cisplatin‐resistant cancer cells with decreased ATP‐dependent drug transport . Biochem. Biophys. Res. Commun. , 252 , 103 – 110 ( 1998. ). [DOI] [PubMed] [Google Scholar]
  • 12.Kinoshita , S. , Suzuki , H. , Ito , K. , Kume , K. , Shimizu , T. . and Sugiyama , Y.Transfected rat cMOAT is functionally expressed on the apical membrane in Madin‐Darby canine kidney (MDCK) cells . Pharmacol. Res. , 15 , 1851 – 1856 ( 1998. ). [DOI] [PubMed] [Google Scholar]
  • 13.Evers , R. , Kool , M. , van Deemter , L. , Janssen , H. , Calafat , J. , Oomen , L. C. , Paulusma , C. C. , Oude Elferink , R. P. , Baas , F. , Schinkel , A. H. . and Borst , P.Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA . J. Clin. Invest. , 101 , 1310 – 1319 ( 1998. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Koike , K. , Kawabe , T. , Tanaka , T. , Toh , S. , Uchiumi , T. , Wada , M. , Akiyama , S. , Ono , M. . and Kuwano , M.A canalicular multispecific organic anion transporter (cMOAT) antisense cDNA enhances drug sensitivity in human hepatic cancer cells . Cancer Res. , 57 , 5475 – 5479 ( 1997. ). [PubMed] [Google Scholar]
  • 15.Kool , M. , van der Linden , M. , de Haas , M. , Scheffer , G. L. , de Vree , J. M. , Smith , A. J. , Jansen , G. , Peters , G. J. , Ponne , N. , Scheper , R. J. , Elferink , R. P. , Baas , F. . and Borst , P.MRP3, an organic anion transporter able to transport anti‐cancer drugs . Proc. Natl. Acad. Sci. USA , 96 , 6914 – 6919 ( 1999. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Hirohashi , T. , Suzuki , H. . and Sugiyama , Y.Characterization of the transport properties of cloned rat multidrug resistance‐associated protein 3 (MRP3) . J. Biol. Chem. , 274 , 15181 – 15185 ( 1999. ). [DOI] [PubMed] [Google Scholar]
  • 17.Suzuki , T. , Nishio , K. , Sasaki , H. , Kurokawa , H. , Saito‐Ohara , F. , Ikeuchi , T. , Tanabe , S. , Terada , M. . and Saijo , N.cDNA cloning of a short type of multidrug resistance protein homologue, SMRP, from a human lung cancer cell line . Biochem. Biophys. Res. Commun. , 238 , 790 – 794 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 18.Avellanosa , A. M. , West , C. R. , Tsukada , Y. , Higby , D. J. , Bakshi , S. , Reese , P. A. and Jennings , E.Chemotherapy of nonirradiated malignant gliomas. Phase II: study of the combination of methyl‐CCNU, vincristine, and procarbazine . Cancer , 44 , 839 – 846 ( 1979. ). [DOI] [PubMed] [Google Scholar]
  • 19.Shapiro , W. R. , Green , S. B. , Burger , P. C. , Mahaley , M. S. , Jr. , Selker , R. G. , VanGilder , J. C. , Robertson , J. T. , Ransohoff , J. , Mealey , J. , Jr. , Strike , T. A. . and Pistenmaa , A.Randomized trial of three chemotherapy regimens and two radiotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001 . J. Neurosurg. , 71 , 1 – 9 ( 1989. ). [DOI] [PubMed] [Google Scholar]
  • 20.Cordon‐Cardo , C. , O'Brien , J. P. , Casals , D. , Rittman‐Grauer , L. , Biedler , J. L. , Melamed , M. R. . and Bertino , J. R.Multidrug‐resistance gene (P‐glycoprotein) is expressed by endothelial cells at blood‐brain barrier sites . Proc. Natl. Acad. Sci. USA , 86 , 695 – 698 ( 1989. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Schinkel , A. H. , Smit , J. J. , van Tellingen , O. , Beijnen , J. H. , Wagenaar , E. , van Deemter , L. , Mol , C. A. , van der Valk , M. A. , Robanus‐Maandag , E. C. , te Riele , H. P.Berns , A. J. M. . and Borst , P.Disruption of the mouse mdrla P‐glycoprotein gene leads to a deficiency in the blood‐brain barrier and to increased sensitivity to drugs . Cell , 77 , 491 – 502 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 22.Matsumoto , T. , Tani , E. , Kaba , K. , Shindo , H. . and Miyaji , K.Expression of P‐glycoprotein in human glioma cell lines and surgical glioma specimens . J. Neurosurg. , 74 , 460 – 466 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 23.Abe , T. , Mori , T. , Wakabayashi , Y. , Nakagawa , M. , Cole , S. P. , Koike , K. , Kuwano , M. . and Hori , S.Expression of multidrug resistance protein gene in patients with glioma after chemotherapy . J. Neurooncol , 40 , 11 – 18 ( 1998. ). [DOI] [PubMed] [Google Scholar]
  • 24.Abe , T. , Koike , K. , Ohga , T. , Kubo , T. , Wada , M. , Kohno , K. , Mori , T. , Hidaka , K. . and Kuwano , M.Chemosensitization of spontaneous multidrug resistance by a 1,4 dihydropyridine analogue and verapamil in human glioma cell lines overexpressing MRP or MDR1 . Br. J. Cancer , 72 , 418 – 423 ( 1995. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Gibson , U. E. , Heid , C. A. . and Williams , P. M.A novel method for real time quantitative RT‐PCR . Genome Res. , 6 , 995 – 1001 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 26.Hinoshita , E. , Uchiumi , T. , Taguchi , K. , Kinugawa , N. , Maehara , Y. , Tsuneyoshi , M. , Sugimachi , K. . and Kuwano , M.Increased expression of an ABC superfamily transporter, multidrug resistance protein 2 (MRP2) in human colorectal carcinomas . Clin. Cancer Res. , 6 , 2401 – 2407 ( 2000. ). [PubMed] [Google Scholar]
  • 27.Hipfner , D. R. , Almquist , K. C. , Stride , B. D. , Deeley , R. G. . and Cole , S. P.Location of a protease hypersensitive region in the multidrug resistance protein (MRP) by mapping of the epitope of MRP‐specific monoclonal antibody QCRL‐1 . Cancer Res. , 56 , 3307 – 3314 ( 1996. ). [PubMed] [Google Scholar]
  • 28.Takano , H. , Kohno , K. , Ono , M. , Uchida , Y. . and Kuwano , M.Increased phosphorylation of DNA topoisomerase II in etoposide‐resistant mutants of human cancer KB cells . Cancer Res. , 51 , 3951 – 3957 ( 1991. ). [PubMed] [Google Scholar]
  • 29.Chen , Z. , Kawabe , T. , Ono , M. , Aoki , S. , Sumizawa , T. , Furukawa , T. , Uchiumi , T. , Wada , M. , Kuwano , M. . and Akiyama , S.Effect of multidrug resistance reversing agents on the transporting activity of human canalicular multispecific organic anion transporter (cMOAT) . Mol. Pharmacol. , 56 , 1219 – 1228 ( 1999. ). [DOI] [PubMed] [Google Scholar]
  • 30.Kawabe , T. , Chen , Z. , Wada , M. , Uchiumi , T. , Ono , M. , Akiyama , S. . and Kuwano , M.Enhanced transport of anti‐cancer agents and leukotriene C4 by the human canalicular multispecific organic anion transporter (cMOAT/MRP2) . FEBS Lett. , 456 , 327 – 331 ( 1999. ). [DOI] [PubMed] [Google Scholar]
  • 31.Cui , Y. , Konig , J. , Buchholz , J. K. , Spring , H. , Leier , I. . and Keppler , D.Drug resistance and ATP dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells . Mol. Pharmacol. , 55 , 929 – 937 ( 1999. ). [PubMed] [Google Scholar]
  • 32.Young , L. C. , Campling , B. G. , Voskoglou‐Nomikos , T. , Cole , S. P. , Deeley , R. G. . and Gerlach , J. H.Expression of multidrug resistance protein‐related genes in lung cancer: correlation with drug response . Clin. Cancer Res. , 5 , 673 – 680 ( 1999. ). [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES